Salient Capital Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-8,690
Closed -$650K 147
2017
Q2
$650K Sell
8,690
-2,578
-23% -$183K 0.01% 138
2017
Q1
$750K Sell
11,268
-597
-5% -$39.8K 0.01% 150
2016
Q4
$774K Sell
11,865
-56
-0.5% -$3.63K 0.01% 140
2016
Q3
$843K Buy
11,921
+318
+3% +$23.2K 0.02% 124
2016
Q2
$858K Sell
11,603
-2,597
-18% -$179K 0.02% 131
2016
Q1
$922K Sell
14,200
-676
-5% -$46K 0.03% 128
2015
Q4
$1.15M Sell
14,876
-10,736
-42% -$853K 0.03% 115
2015
Q3
$2.11M Sell
25,612
-4,547
-15% -$405K 0.05% 96
2015
Q2
$2.66M Buy
30,159
+1,690
+6% +$155K 0.05% 101
2015
Q1
$2.52M Sell
28,469
-219
-0.8% -$19.4K 0.05% 97
2014
Q4
$2.38M Buy
28,688
+1,887
+7% +$156K 0.05% 99
2014
Q3
$2.26M Buy
26,801
+4,169
+18% +$337K 0.04% 111
2014
Q2
$1.84M Buy
22,632
+3,060
+16% +$241K 0.04% 110
2014
Q1
$1.49M Buy
19,572
+12,249
+167% +$893K 0.04% 114
2013
Q4
$528K Buy
7,323
+2,132
+41% +$148K 0.02% 153
2013
Q3
$357K Sell
5,191
-506
-9% -$33.5K 0.01% 137
2013
Q2
$361K Buy
+5,697
New +$371K 0.02% 135

Other funds holding NVS